Becton Dickinson Price to Sales Ratio 2010-2025 | BDX
Historical PS ratio values for Becton Dickinson (BDX) over the last 10 years. The current P/S ratio for Becton Dickinson as of June 27, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Becton Dickinson P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-06-27 |
170.86 |
|
2.37 |
| 2025-03-31 |
227.69 |
$71.99 |
3.16 |
| 2024-12-31 |
224.49 |
$71.05 |
3.16 |
| 2024-09-30 |
237.44 |
$69.40 |
3.42 |
| 2024-06-30 |
229.22 |
$68.36 |
3.35 |
| 2024-03-31 |
241.74 |
$68.11 |
3.55 |
| 2023-12-31 |
237.24 |
$67.61 |
3.51 |
| 2023-09-30 |
250.52 |
$67.53 |
3.71 |
| 2023-06-30 |
254.96 |
$66.46 |
3.84 |
| 2023-03-31 |
238.19 |
$65.67 |
3.63 |
| 2022-12-31 |
243.75 |
$65.33 |
3.73 |
| 2022-09-30 |
212.80 |
$65.71 |
3.24 |
| 2022-06-30 |
234.64 |
$63.87 |
3.67 |
| 2022-03-31 |
246.16 |
$63.50 |
3.88 |
| 2021-12-31 |
231.96 |
$63.68 |
3.64 |
| 2021-09-30 |
225.94 |
$65.36 |
3.46 |
| 2021-06-30 |
222.80 |
$63.88 |
3.49 |
| 2021-03-31 |
222.00 |
$61.62 |
3.60 |
| 2020-12-31 |
227.68 |
$60.36 |
3.77 |
| 2020-09-30 |
210.99 |
$57.60 |
3.66 |
| 2020-06-30 |
216.23 |
$61.04 |
3.54 |
| 2020-03-31 |
206.97 |
$63.37 |
3.27 |
| 2019-12-31 |
244.17 |
$63.45 |
3.85 |
| 2019-09-30 |
226.42 |
$63.25 |
3.58 |
| 2019-06-30 |
224.89 |
$63.21 |
3.56 |
| 2019-03-31 |
222.14 |
$62.97 |
3.53 |
| 2018-12-31 |
199.81 |
$63.22 |
3.16 |
| 2018-09-30 |
230.71 |
$61.44 |
3.76 |
| 2018-06-30 |
211.14 |
$58.96 |
3.58 |
| 2018-03-31 |
190.38 |
$57.09 |
3.33 |
| 2017-12-31 |
187.41 |
$54.93 |
3.41 |
| 2017-09-30 |
170.97 |
$54.96 |
3.11 |
| 2017-06-30 |
169.61 |
$55.65 |
3.05 |
| 2017-03-31 |
158.86 |
$56.62 |
2.81 |
| 2016-12-31 |
142.80 |
$57.15 |
2.50 |
| 2016-09-30 |
154.34 |
$57.54 |
2.68 |
| 2016-06-30 |
145.10 |
$57.43 |
2.53 |
| 2016-03-31 |
129.39 |
$57.23 |
2.26 |
| 2015-12-31 |
130.74 |
$53.33 |
2.45 |
| 2015-09-30 |
112.07 |
$49.93 |
2.24 |
| 2015-06-30 |
119.14 |
$46.32 |
2.57 |
| 2015-03-31 |
120.26 |
$42.76 |
2.81 |
| 2014-12-31 |
116.08 |
$42.99 |
2.70 |
| 2014-09-30 |
94.52 |
$42.75 |
2.21 |
| 2014-06-30 |
97.79 |
$42.16 |
2.32 |
| 2014-03-31 |
96.34 |
$41.54 |
2.32 |
| 2013-12-31 |
90.49 |
$41.14 |
2.20 |
| 2013-09-30 |
81.50 |
$40.49 |
2.01 |
| 2013-06-30 |
80.13 |
$39.35 |
2.04 |
| 2013-03-31 |
77.13 |
$38.66 |
1.99 |
| 2012-12-31 |
62.72 |
$37.76 |
1.66 |
| 2012-09-30 |
62.62 |
$36.66 |
1.71 |
| 2012-06-30 |
59.23 |
$35.51 |
1.67 |
| 2012-03-31 |
61.15 |
$34.60 |
1.77 |
| 2011-12-31 |
58.49 |
$33.93 |
1.72 |
| 2011-09-30 |
57.04 |
$33.42 |
1.71 |
| 2011-06-30 |
66.69 |
$31.93 |
2.09 |
| 2011-03-31 |
61.33 |
$30.88 |
1.99 |
| 2010-12-31 |
64.76 |
$29.83 |
2.17 |
| 2010-09-30 |
56.49 |
$29.61 |
1.91 |
| 2010-06-30 |
51.28 |
$29.83 |
1.72 |
| 2010-03-31 |
59.39 |
$29.55 |
2.01 |
| 2009-12-31 |
59.21 |
$29.10 |
2.03 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$48.715B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
